-transparent.png){kind=logo}
The tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits the humoral immune response of lymphocytes to antigen. To test the hypothesis that this inhibition is due to a direct effect upon B lymphocytes, splenic lymphocytes or murine B lymphocytes, enriched by 'panning' splenic lymphocytes onto anti-IgM-coated petri dishes, were immunized in vitro with the thymus/accessory cell-independent antigen trinitrophenyl lipopolysaccharide (TNP-LPS) with or without TPA. The number of anti-TNP antibody-forming cells present in both lymphocyte populations after 5 days was almost completely inhibited to the same degree by TPA. These data unambiguously show that TPA can directly inhibit the differentiation of B lymphocytes to antibody-forming cells.
L D Schuman, and
T M Petro, and
C S Baxter
November 1981,
Biochemical and biophysical research communications,
L D Schuman, and
T M Petro, and
C S Baxter
January 1982,
Carcinogenesis; a comprehensive survey,
L D Schuman, and
T M Petro, and
C S Baxter
May 1979,
Journal of immunology (Baltimore, Md. : 1950),
L D Schuman, and
T M Petro, and
C S Baxter
November 1981,
Thymus,
L D Schuman, and
T M Petro, and
C S Baxter
November 1983,
Experimental hematology,
L D Schuman, and
T M Petro, and
C S Baxter
January 1991,
Oncology,
L D Schuman, and
T M Petro, and
C S Baxter
October 1990,
Leukemia,
L D Schuman, and
T M Petro, and
C S Baxter
January 1984,
IARC scientific publications,
L D Schuman, and
T M Petro, and
C S Baxter
May 1987,
Cancer letters,
L D Schuman, and
T M Petro, and
C S Baxter
March 1980,
Cancer research,
